{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T13:35:00Z","timestamp":1795008900592,"version":"4.9.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["Ronghua Jin"],"award-info":[{"award-number":["Ronghua Jin"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>To overcome the inherent limitations of conventional nanocarriers such as therapeutic inefficacy and suboptimal drug loading capacity, a novel \u201cpolymeric nanodrug\u201d strategy was developed. This approach redefines nanodrug design by employing glycyrrhetinic acid (GA) simultaneously as a bioactive agent and a polymerizable targeting monomer to synthesize poly-glycyrrhetinic acid (PGA), achieving near-theoretical drug loading approaching 100%. Subsequent PEGylation yielded hepatocellular carcinoma (HCC)-targeting PGA-PEG-GA nanodrugs, which exhibited a 1.89-fold enhancement in antitumor efficacy compared to free GA. The exceptionally low critical micelle concentration (CMC) of PGA-PEG-GA enables efficient encapsulation of additional therapeutics. Using doxorubicin (DOX) as a model drug, HCC-targeting nanodrugs (denoted as DOX@PGA-PEG-GA NDs) were fabricated. In vitro studies demonstrated that the nanodrugs induced 2.5-fold higher toxicity in tumor cells than normal cells, enhanced cellular uptake by 3.0-fold, and reduced DOX-induced cardiomyocyte apoptosis by 54%. In vivo evaluations revealed a tumor inhibition rate of 89.7\u2009\u00b1\u20095.2% for DOX@PGA-PEG-GA NDs and 40.09\u2009\u00b1\u200911.94% for blank PGA-PEG-GA NDs, together with 18.3-fold higher intra-tumoral accumulation compared to free DOX and complete mitigation of DOX-related cardiotoxicity. This integrated \u201cstructure-function-safety\u201d strategy effectively overcomes critical challenges in drug-loading efficiency and functional synergy, offering a robust and novel platform for targeted nanodrug applications.<\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical Abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1186\/s12951-025-03765-5","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T15:48:25Z","timestamp":1762962505000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Reengineering glycyrrhetinic acid into a therapeutic oligomer for targeted tumor therapy with cardioprotection"],"prefix":"10.1186","volume":"23","author":[{"given":"Zixin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alu","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZiXuan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingyun","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronghua","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"issue":"11","key":"3765_CR1","doi-asserted-by":"publisher","first-page":"4391","DOI":"10.1016\/j.apsb.2023.05.018","volume":"13","author":"Q Liu","year":"2023","unstructured":"Liu Q, Zou J, Chen Z, He W, Wu W. Current research trends of nanomedicines. Acta Pharm Sin B. 2023;13(11):4391\u2013416.","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"3765_CR2","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.apsb.2024.12.007","volume":"15","author":"Y Liu","year":"2025","unstructured":"Liu Y, Zhang Y, Li H, Hu TY. Recent advances in the bench-to-bedside translation of cancer nanomedicines. Acta Pharm Sin B. 2025;15(1):97\u2013122.","journal-title":"Acta Pharm Sin B"},{"key":"3765_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124231","volume":"658","author":"Z Xu","year":"2024","unstructured":"Xu Z, Lin H, Dai J, Wen X, Yu X, Xu C, et al. Protein-nanoparticle co-assembly supraparticles for drug delivery: ultrahigh drug loading and colloidal stability, and instant and complete lysosomal drug release. Int J Pharm. 2024;658:124231.","journal-title":"Int J Pharm"},{"issue":"4","key":"3765_CR4","doi-asserted-by":"publisher","first-page":"4306","DOI":"10.1021\/acsomega.8b00427","volume":"3","author":"R Jin","year":"2018","unstructured":"Jin R, Liu Z, Bai Y, Zhou Y, Chen X. Multiple-responsive mesoporous silica nanoparticles for highly accurate drugs delivery to tumor cells. ACS Omega. 2018;3(4):4306\u201315.","journal-title":"ACS Omega"},{"issue":"1","key":"3765_CR5","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1021\/acsanm.7b00152","volume":"1","author":"R Jin","year":"2018","unstructured":"Jin R, Liu Z, Bai Y, Zhou Y, Chen X. Effective control of enzyme activity based on a subtle nanoreactor: a promising strategy for biomedical applications in the future. ACS Appl Nano Mater. 2018;1(1):302\u20139.","journal-title":"ACS Appl Nano Mater"},{"key":"3765_CR6","doi-asserted-by":"crossref","unstructured":"Jin R, Liu Z, Bai Y, Zhou Y, Gooding JJ, Chen X. Core\u2013satellite mesoporous silica\u2013gold nanotheranostics for biological stimuli triggered multimodal cancer therapy. Adv Funct Mater. 2018; 28(31):1801961.","DOI":"10.1002\/adfm.201801961"},{"key":"3765_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpolymj.2019.08.018","volume":"120","author":"SK Prajapati","year":"2019","unstructured":"Prajapati SK, Jain A, Jain A, Jain S. Biodegradable polymers and constructs: a novel approach in drug delivery. Eur Polym J. 2019;120:109191.","journal-title":"Eur Polym J"},{"issue":"2","key":"3765_CR8","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","volume":"160","author":"Y Barenholz","year":"2012","unstructured":"Barenholz Y. Doxil\u00ae - the first FDA-approved nano-drug: lessons learned. J Control Release. 2012;160(2):117\u201334.","journal-title":"J Control Release"},{"key":"3765_CR9","doi-asserted-by":"crossref","unstructured":"Yang L, Cao F, Lu J, Wu S, Wang L, She J, He B, Xu X, Shi F, Gao Y, Ye Z, Guo B, Kong L, Jin R, Cai B. Neutrophil Membrane-Encapsulated Polymerized Salicylic Acid Nanoparticles Effectively Alleviating Rheumatoid Arthritis by Facilitating Sustained Release of Salicylic Acid into the Articular Cavity from Chondrocytes. Adv Healthc Mater. 2025;14(12):e2404510.","DOI":"10.1002\/adhm.202404510"},{"issue":"12","key":"3765_CR10","first-page":"1089","volume":"22","author":"M Xiao","year":"2024","unstructured":"Xiao M, Guo Z, Yang Y, Hu C, Cheng Q, Zhang C, Wu Y, Cheng Y, Benson WL, M, Shamay SM, N, et al. Glycyrrhizic acid-based multifunctional nanoplatform for tumor microenvironment regulation. Chin J Nat Med. 2024;22(12):1089\u201399.","journal-title":"Chin J Nat Med"},{"key":"3765_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2022.100327","volume":"15","author":"Y Hou","year":"2022","unstructured":"Hou Y, Zou L, Li Q, Chen M, Ruan H, Sun Z, et al. Supramolecular assemblies based on natural small molecules: union would be effective. Mater Today Bio. 2022;15:100327.","journal-title":"Mater Today Bio"},{"issue":"2","key":"3765_CR12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.53388\/BMEC2023008","volume":"2","author":"G-Q Ju","year":"2023","unstructured":"Ju G-Q, Wu F-C, Zhou L-H, Yuan F. -W. CRISPR system contributes to Deciphering the pharmaceutical compounds from TCM. Biomed Eng Commun. 2023;2(2):8.","journal-title":"Biomed Eng Commun"},{"issue":"3","key":"3765_CR13","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1021\/acs.molpharmaceut.5b00677","volume":"13","author":"Y Cai","year":"2016","unstructured":"Cai Y, Xu Y, Chan HF, Fang X, He C, Chen M. Glycyrrhetinic acid mediated drug delivery carriers for hepatocellular carcinoma therapy. Mol Pharm. 2016;13(3):699\u2013709.","journal-title":"Mol Pharm"},{"key":"3765_CR14","doi-asserted-by":"publisher","first-page":"154757","DOI":"10.1016\/j.phymed.2023.154757","volume":"114","author":"Y Cheng","year":"2023","unstructured":"Cheng Y, Zhong X, Nie X, Gu H, Wu X, Li R, Wu Y, Lv K, Leung GP-H, Fu C, et al. Glycyrrhetinic acid suppresses breast cancer metastasis by inhibiting M2-like macrophage polarization via activating JNK1\/2 signaling. Phytomedicine. 2023;114:154757.","journal-title":"Phytomedicine"},{"issue":"10","key":"3765_CR15","doi-asserted-by":"publisher","first-page":"3376","DOI":"10.1007\/s11095-015-1714-2","volume":"32","author":"J Zhang","year":"2015","unstructured":"Zhang J, Zhang M, Ji J, Fang X, Pan X, Wang Y, et al. Glycyrrhetinic acid-mediated polymeric drug delivery targeting the acidic microenvironment of hepatocellular carcinoma. Pharm Res. 2015;32(10):3376\u201390.","journal-title":"Pharm Res"},{"key":"3765_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.124370","volume":"240","author":"L Cui","year":"2023","unstructured":"Cui L, Wang X, Liu Z, Li Z, Bai Z, Lin K, et al. Metal-organic framework decorated with glycyrrhetinic acid conjugated chitosan as a pH-responsive nanocarrier for targeted drug delivery. Int J Biol Macromol. 2023;240:124370.","journal-title":"Int J Biol Macromol"},{"key":"3765_CR17","volume":"2014","author":"J-y Li","year":"2014","unstructured":"Li J-y, Cao H-y, Liu P, Cheng G-h, Sun M-y. Glycyrrhizic acid in the treatment of liver diseases: literature review. Biomed Res Int. 2014;2014:872139.","journal-title":"Biomed Res Int"},{"key":"3765_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmt.2024.102102","volume":"37","author":"R Jin","year":"2024","unstructured":"Jin R, Li J, Huang B, Lu J, Huang J, Wu L, et al. Amelioration of osteoarthritis through Salicylic acid nano-formulated self-therapeutic prodrug for the prolonged launch of Salicylic acid to damaged cartilage. Appl Mater Today. 2024;37:102102.","journal-title":"Appl Mater Today"},{"key":"3765_CR19","doi-asserted-by":"crossref","unstructured":"Lu J, Li Y, Qin X, Wang Z, Ouyang A, Su B, Guo H, Yang X, Shen Z, Li J, Fan L, Xie Y, Jin R. A clinically inspired olsalazine-based metal-organic framework enables a universal nanodrugs platform for diverse disease. J Colloid Interface Sci. 2025;702(1):138849.","DOI":"10.1016\/j.jcis.2025.138849"},{"key":"3765_CR20","first-page":"212","volume":"40","author":"J Guo","year":"2024","unstructured":"Guo J, Su K, Wang L, Feng B, You X, Deng M, et al. Poly(p-coumaric acid) nanoparticles alleviate temporomandibular joint osteoarthritis by inhibiting chondrocyte ferroptosis. Bioact Mater. 2024;40:212\u201326.","journal-title":"Bioact Mater"},{"issue":"9","key":"3765_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.201907857","volume":"30","author":"K Ou","year":"2019","unstructured":"Ou K, Xu X, Guan S, Zhang R, Zhang X, Kang Y, et al. Nanodrug carrier based on poly(ursolic acid) with self-anticancer activity against colorectal cancer. Adv Funct Mater. 2019;30(9):1907857.","journal-title":"Adv Funct Mater"},{"issue":"33","key":"3765_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202100805","volume":"31","author":"X You","year":"2021","unstructured":"You X, Wang L, Wang L, Wu J. Rebirth of aspirin synthesis by-product: prickly poly(salicylic acid) nanoparticles as self\u2010anticancer drug carrier. Adv Funct Mater. 2021;31(33):2100805.","journal-title":"Adv Funct Mater"},{"key":"3765_CR23","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.ejpb.2014.12.015","volume":"94","author":"AC Braun","year":"2015","unstructured":"Braun AC, Ilko D, Merget B, Gieseler H, Germershaus O, Holzgrabe U, et al. Predicting critical micelle concentration and micelle molecular weight of polysorbate 80 using compendial methods. Eur J Pharm Biopharm. 2015;94:559\u201368.","journal-title":"Eur J Pharm Biopharm"},{"key":"3765_CR24","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jiec.2016.11.032","volume":"47","author":"D \u0106irin","year":"2017","unstructured":"\u0106irin D, Krstono\u0161i\u0107 V, Po\u0161a M. Properties of poloxamer 407 and polysorbate mixed micelles: influence of polysorbate hydrophobic chain. J Ind Eng Chem. 2017;47:194\u2013201.","journal-title":"J Ind Eng Chem"},{"issue":"3","key":"3765_CR25","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/j.actbio.2013.12.033","volume":"10","author":"W Hong","year":"2014","unstructured":"Hong W, Chen DW, Jia L, Gu JC, Hu HY, Zhao XL, et al. Thermo- and pH-responsive copolymers based on PLGA-PEG-PLGA and poly(L-histidine): synthesis and in vitro characterization of copolymer micelles. Acta Biomater. 2014;10(3):1259\u201371.","journal-title":"Acta Biomater"},{"issue":"3","key":"3765_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpha.2024.101044","volume":"15","author":"X Ji","year":"2025","unstructured":"Ji X, Raza A, Qi J, Lu Y, He H, Wu W. A high-throughput measurement of critical micelle concentrations based on absolute aggregation-caused quenching probes. J Pharm Anal. 2025;15(3):101044.","journal-title":"J Pharm Anal"},{"key":"3765_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.surfin.2019.100427","volume":"18","author":"S Tiwari","year":"2020","unstructured":"Tiwari S, Mall C, Solanki PP. CMC studies of CTAB, SLS & tween 80 by spectral and conductivity methodology to explore its potential in photogalvanic cell. Surf Interface. 2020;18:100427.","journal-title":"Surf Interface"},{"key":"3765_CR28","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jconrel.2014.03.026","volume":"183","author":"K Zhang","year":"2014","unstructured":"Zhang K, Tang X, Zhang J, Lu W, Lin X, Zhang Y, et al. PEG-PLGA copolymers: their structure and structure-influenced drug delivery applications. J Control Release. 2014;183:77\u201386.","journal-title":"J Control Release"},{"issue":"758","key":"3765_CR29","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.abn8017","volume":"15","author":"K Abe","year":"2022","unstructured":"Abe K, Ikeda M, Ide T, Tadokoro T, Miyamoto HD, Furusawa S, et al. Doxorubicin causes ferroptosis and cardiotoxicity by intercalating into mitochondrial DNA and disrupting Alas1-dependent Heme synthesis. Sci Signal. 2022;15(758):eabn8017.","journal-title":"Sci Signal"},{"issue":"32","key":"3765_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202401945","volume":"11","author":"M Bao","year":"2024","unstructured":"Bao M, Hua X, Chen X, An T, Mo H, Sun Z, et al. PICALM regulating the generation of amyloid \u03b2-peptide to promote Anthracycline-induced cardiotoxicity. Adv Sci. 2024;11(32):2401945.","journal-title":"Adv Sci"},{"issue":"11","key":"3765_CR31","doi-asserted-by":"publisher","first-page":"E223","DOI":"10.1161\/CIRCRESAHA.122.321587","volume":"132","author":"W Luo","year":"2023","unstructured":"Luo W, Zou X, Wang Y, Dong Z, Weng X, Pei Z, et al. Critical role of the cGAS-STING pathway in Doxorubicin-induced cardiotoxicity. Circ Res. 2023;132(11):E223-42.","journal-title":"Circ Res"},{"issue":"11","key":"3765_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cclet.2024.109620","volume":"35","author":"J Xu","year":"2024","unstructured":"Xu J, Zhang W, Cai Z, Li Y, Bai L, Gao S, et al. Tetrahedron DNA nanostructure\/iron-based nanomaterials for combined tumor therapy. Chin Chem Lett. 2024;35(11):109620.","journal-title":"Chin Chem Lett"},{"key":"3765_CR33","doi-asserted-by":"publisher","first-page":"154407","DOI":"10.1016\/j.phymed.2022.154407","volume":"106","author":"Y Cheng","year":"2022","unstructured":"Cheng Y, Wu X, Nie X, Wu Y, Zhang C, Lee SM-Y, Lv K, Leung GP-H, Fu C, Zhang J, et al. Natural compound glycyrrhetinic acid protects against doxorubicin-induced cardiotoxicity by activating the Nrf2\/HO-1 signaling pathway. Phytomedicine. 2022;106:154407.","journal-title":"Phytomedicine"},{"key":"3765_CR34","doi-asserted-by":"publisher","first-page":"153408","DOI":"10.1016\/j.phymed.2020.153408","volume":"81","author":"J Shi","year":"2021","unstructured":"Shi J, Li J, Li J, Li R, Wu X, Gao F, Zou L, Mak WWS, Fu C, Zhang J, et al. Synergistic breast cancer suppression efficacy of doxorubicin by combination with glycyrrhetinic acid as an angiogenesis inhibitor. Phytomedicine. 2021;81:153408.","journal-title":"Phytomedicine"},{"key":"3765_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202303614","volume":"35","author":"R Zhang","year":"2023","unstructured":"Zhang R, Shao S, Piao Y, Xiang J, Wei X, Zhang Z, et al. Esterase-labile quaternium lipidoid enabling improved mRNA-LNP stability and spleen-selective mRNA transfection. Adv Mater. 2023;35:2303614.","journal-title":"Adv Mater"},{"issue":"13","key":"3765_CR36","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1002\/jcc.21224","volume":"30","author":"L Mart\u00ednez","year":"2009","unstructured":"Mart\u00ednez L, Andrade R, Birgin EG, Mart\u00ednez JM. Packmol: a package for building initial configurations for molecular dynamics simulations. J Comput Chem. 2009;30(13):2157\u201364.","journal-title":"J Comput Chem"},{"issue":"24","key":"3765_CR37","doi-asserted-by":"publisher","first-page":"6269","DOI":"10.1021\/j100308a038","volume":"91","author":"HJC Berendsen","year":"1987","unstructured":"Berendsen HJC, Grigera JR, Straatsma TP. The missing term in effective pair potentials. J Phys Chem A. 1987;91(24):6269\u201371.","journal-title":"J Phys Chem A"},{"issue":"3","key":"3765_CR38","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0021-9991(77)90098-5","volume":"23","author":"J-P Ryckaert","year":"1977","unstructured":"Ryckaert J-P, Ciccotti G, Berendsen HJC. Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J Comput Phys. 1977;23(3):327\u201341.","journal-title":"J Comput Phys"},{"issue":"5","key":"3765_CR39","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1021\/mp5000373","volume":"11","author":"Y Liu","year":"2014","unstructured":"Liu Y, Fang J, Kim YJ, Wong MK, Wang P. Codelivery of doxorubicin and paclitaxel by cross-linked multilamellar liposome enables synergistic antitumor activity. Mol Pharm. 2014;11(5):1651\u201361.","journal-title":"Mol Pharm"},{"issue":"5","key":"3765_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115681","volume":"44","author":"J Chen","year":"2025","unstructured":"Chen J, Huang C, Mei J, Lin Q, Chen W, Tang J, et al. Otud4 inhibits ferroptosis by stabilizing GPX4 and suppressing autophagic degradation to promote tumor progression. Cell Rep. 2025;44(5):115681.","journal-title":"Cell Rep"},{"issue":"43","key":"3765_CR41","doi-asserted-by":"publisher","first-page":"58489","DOI":"10.1021\/acsami.4c15320","volume":"16","author":"Y Xiao","year":"2024","unstructured":"Xiao Y, Ouyang A, Fan L, Qin X, Li Y, Wang Z, et al. Precision delivery of binary cooperative nanodrugs self-assembled by Berberine glycyrrhetinic acid salts for hepatocellular carcinoma treatment. ACS Appl Mater Interfaces. 2024;16(43):58489\u2013505.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"10","key":"3765_CR42","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.1016\/j.cclet.2021.03.084","volume":"32","author":"R Jin","year":"2021","unstructured":"Jin R, Liu Z, Liu T, Yuan P, Bai Y, Chen X. Redox-responsive micelles integrating catalytic nanomedicine and selective chemotherapy for effective tumor treatment. Chin Chem Lett. 2021;32(10):3076\u201382.","journal-title":"Chin Chem Lett"},{"key":"3765_CR43","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jconrel.2016.03.035","volume":"230","author":"Q Wang","year":"2016","unstructured":"Wang Q, Jiang J, Chen W, Jiang H, Zhang Z, Sun X. Targeted delivery of low-dose dexamethasone using PCL-PEG micelles for effective treatment of rheumatoid arthritis. J Control Release. 2016;230:64\u201372.","journal-title":"J Control Release"},{"key":"3765_CR44","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.actbio.2020.10.015","volume":"122","author":"Y Wang","year":"2021","unstructured":"Wang Y, Xu XW, Zhao X, Yin ZN. Functionalized polymeric hybrid micelles as an efficient nanotheranostic agent for thrombus imaging and thrombolysis. Acta Biomater. 2021;122:278\u201390.","journal-title":"Acta Biomater"},{"issue":"5","key":"3765_CR45","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/s41551-018-0234-x","volume":"2","author":"Y Lu","year":"2018","unstructured":"Lu Y, Yue Z, Xie J, Wang W, Zhu H, Zhang E, Cao Z. Micelles with ultralow critical micelle concentration as carriers for drug delivery. Nat Biomed Eng. 2018;2(5):318\u201325.","journal-title":"Nat Biomed Eng"},{"key":"3765_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmt.2020.100883","volume":"21","author":"R Jin","year":"2020","unstructured":"Jin R, Wang Q, Dou G, Bai Y, Liu S, Cai B, et al. Stimuli responsive nanoplatform with mitochondria-specific multiple model therapeutics for effective tumor treatment. Appl Mater Today. 2020;21:100883.","journal-title":"Appl Mater Today"},{"key":"3765_CR47","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.actbio.2019.09.009","volume":"101","author":"S Thakkar","year":"2020","unstructured":"Thakkar S, Sharma D, Kalia K, Tekade RK. Tumor microenvironment targeted nanotherapeutics for cancer therapy and diagnosis: a review. Acta Biomater. 2020;101:43\u201368.","journal-title":"Acta Biomater"},{"key":"3765_CR48","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.jconrel.2023.03.015","volume":"356","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Zhou J, Chen X, Li Z, Gu L, Pan D, et al. Modulating tumor-stromal crosstalk via a redox-responsive nanomedicine for combination tumor therapy. J Controlled Release. 2023;356:525\u201341.","journal-title":"J Controlled Release"},{"key":"3765_CR49","doi-asserted-by":"crossref","unstructured":"Shen N, Zhao W, Chu H, Yu H, Sun H, Tang Z, Chen X. Targeted delivery and controlled release of polymeric nanomedicines for tumor therapy. Fundam Res. 2025;5(4):1349\u20131368.","DOI":"10.1016\/j.fmre.2025.01.011"},{"key":"3765_CR50","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.jconrel.2023.02.010","volume":"355","author":"N Veiga","year":"2023","unstructured":"Veiga N, Diesendruck Y, Peer D. Targeted nanomedicine: lessons learned and future directions. J Controlled Release. 2023;355:446\u201357.","journal-title":"J Controlled Release"},{"key":"3765_CR51","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.lfs.2017.07.032","volume":"188","author":"Y-q Sun","year":"2017","unstructured":"Sun Y-q, Dai C-m, Zheng Y, Shi S-d, Hu H-y, Chen D-w. Binding effect of fluorescence labeled glycyrrhetinic acid with GA receptors in hepatocellular carcinoma cells. Life Sci. 2017;188:186\u201391.","journal-title":"Life Sci"},{"key":"3765_CR52","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.jconrel.2023.07.006","volume":"360","author":"D Xia","year":"2023","unstructured":"Xia D, Zhang X, Hao H, Jiang W, Chen C, Li H, et al. Strategies to prolong drug retention in solid tumors by aggregating Endo-CMC nanoparticles. J Control Release. 2023;360:705\u201317.","journal-title":"J Control Release"},{"issue":"1","key":"3765_CR53","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/s12951-025-03336-8","volume":"23","author":"S Ma","year":"2025","unstructured":"Ma S, Zhang X, Zhu X, Yan K, Wang Q, Lei L, et al. Dual-modality immune nano-activator harnessing Mn2\u207a and Quercetin to potentiate the cGAS-STING pathway for advanced cancer metalloimmunotherapy. J Nanobiotechnol. 2025;23(1):248.","journal-title":"J Nanobiotechnol"},{"key":"3765_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2024.101326","volume":"29","author":"J Li","year":"2024","unstructured":"Li J, Ma S, Lin Q, Wang Q, Zhong W, Wei C, et al. Orchestrated copper-loaded nanoreactor for simultaneous induction of Cuproptosis and immunotherapeutic intervention in colorectal cancer. Mater Today Bio. 2024;29:101326.","journal-title":"Mater Today Bio"},{"issue":"4","key":"3765_CR55","volume":"19","author":"Z Lin","year":"2024","unstructured":"Lin Z, Wang Y, Li W, Sun F, Lv Q, Zhang S, et al. A natural compound-empowered Podophyllotoxin prodrug nanoassembly magnifies efficacy-toxicity benefits in cancer chemotherapy. Asian J Pharm Sci. 2024;19(4):100892.","journal-title":"Asian J Pharm Sci"},{"key":"3765_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2022.141225","volume":"457","author":"QY Zhang","year":"2023","unstructured":"Zhang QY, Luo QH, Liu ZM, Sun MC, Dong X. Nano-ROS-generating approaches to cancer dynamic therapy: lessons from nanoparticles. Chem Eng J. 2023;457:26.","journal-title":"Chem Eng J"},{"issue":"11","key":"3765_CR57","doi-asserted-by":"publisher","first-page":"3941","DOI":"10.1016\/j.actbio.2012.07.015","volume":"8","author":"RE Fitzsimmons","year":"2012","unstructured":"Fitzsimmons RE, B, Uludag H. Specific effects of pegylation on gene delivery efficacy of polyethylenimine: interplay between PEG substitution and N\/P ratio. Acta Biomater. 2012;8(11):3941\u201355.","journal-title":"Acta Biomater"},{"issue":"5","key":"3765_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.cclet.2023.108752","volume":"35","author":"F Li","year":"2024","unstructured":"Li F, Pei Z, Chen S, li G, Liu M, Ding L, et al. Multifunctional nano-herb based on tumor microenvironment for enhanced tumor therapy of gambogic acid. Chin Chem Lett. 2024;35(5):108752.","journal-title":"Chin Chem Lett"},{"key":"3765_CR59","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cej.2022.137605","volume":"450","author":"XJ Yan","year":"2022","unstructured":"Yan XJ, Ma FH, Chen Q, X, Gou XB, Li XH, Zhang LW, Gao H. Construction of size-transformable supramolecular nano-platform against drug-resistant colorectal cancer caused by Fusobacterium nucleatum. Chem Eng J. 2022;450:12.","journal-title":"Chem Eng J"},{"key":"3765_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2022.137147","volume":"446","author":"ZW Jing","year":"2022","unstructured":"Jing ZW, Du QZ, Zhang XJ, Zhang Y. Nanomedicines and nanomaterials for cancer therapy: progress, challenge and perspectives. Chem Eng J. 2022;446:18.","journal-title":"Chem Eng J"},{"issue":"1","key":"3765_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s11658-025-00708-8","volume":"30","author":"Z Feng","year":"2025","unstructured":"Feng Z, Zhang N, Wang L, Guan X, Xie Y, Xia Y-l. CDC20 protects the heart from doxorubicin-induced cardiotoxicity by modulating CCDC69 degradation. Cell Mol Biol Lett. 2025;30(1):29.","journal-title":"Cell Mol Biol Lett"},{"issue":"5","key":"3765_CR62","first-page":"970","volume":"116","author":"M Gyoengyoesi","year":"2020","unstructured":"Gyoengyoesi M, Lukovic D, Zlabinger K, Spannbauer A, Gugerell A, Pavo N, Traxler D, Pik D, Maurer G, Jakab A, et al. Liposomal doxorubicin attenuates cardiotoxicity via induction of interferon-related DNA damage resistance. Cardiovasc Res. 2020;116(5):970\u201382.","journal-title":"Cardiovasc Res"},{"issue":"2","key":"3765_CR63","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1172\/JCI72931","volume":"124","author":"Y Ichikawa","year":"2014","unstructured":"Ichikawa Y, Ghanefar M, Bayeva M, Wu R, Khechaduri A, Prasad SV, N, Mutharasan RK, Naik TJ, Ardehali H. Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation. J Clin Invest. 2014;124(2):617\u201330.","journal-title":"J Clin Invest"},{"issue":"2","key":"3765_CR64","doi-asserted-by":"publisher","first-page":"760","DOI":"10.7150\/ijbs.65258","volume":"18","author":"C-Y Kong","year":"2022","unstructured":"Kong C-Y, Guo Z, Song P, Zhang X, Yuan Y-P, Teng T, et al. Underlying the mechanisms of doxorubicin-induced acute cardiotoxicity: oxidative stress and cell death. Int J Biol Sci. 2022;18(2):760\u201370.","journal-title":"Int J Biol Sci"},{"issue":"2","key":"3765_CR65","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0168-3659(01)00218-8","volume":"71","author":"YP Li","year":"2001","unstructured":"Li YP, Pei YY, Zhang XY, Gu ZH, Zhou ZH, Yuan WF, Zhou JJ, Zhu JH, Gao X. J. PEGylated PLGA nanoparticles as protein carriers: synthesis, Preparation and biodistribution in rats. J Controlled Release. 2001;71(2):203\u201311.","journal-title":"J Controlled Release"},{"issue":"10","key":"3765_CR66","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/s41578-022-00458-5","volume":"7","author":"ER Brannon","year":"2022","unstructured":"Brannon ER, Guevara MV, Pacifici NJ, Lee JK, Lewis JS, Eniola-Adefeso O. Polymeric particle-based therapies for acute inflammatory diseases. Nat Rev Mater. 2022;7(10):796\u2013813.","journal-title":"Nat Rev Mater"},{"issue":"50","key":"3765_CR67","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abj1083","volume":"7","author":"D-S Kim","year":"2021","unstructured":"Kim D-S, Lee J-K, Kim JH, Lee J, Kim DS, An S, et al. Advanced PLGA hybrid scaffold with a bioactive PDRN\/BMP2 nanocomplex for angiogenesis and bone regeneration using human fetal MSCs. Sci Adv. 2021;7(50):eabj1083.","journal-title":"Sci Adv"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03765-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03765-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03765-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T17:03:11Z","timestamp":1762966991000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-025-03765-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3765"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03765-5","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"assertion":[{"value":"10 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"715"}}